Literature DB >> 8959617

Modulators of crescentic glomerulonephritis.

R C Atkins1, D J Nikolic-Paterson, Q Song, H Y Lan.   

Abstract

Glomerular crescent formation is a prominent feature of aggressive forms of glomerulonephritis and is associated with a poor prognosis. An understanding of the mechanisms involved in crescent formation is crucial for the development of new therapies for this disease. This article reviews current ideas on the pathogenesis of glomerular crescent formation and describes methods for modulation of this process. Emphasis is given to the role of the proinflammatory cytokines interleukin-1 and tumor necrosis factor-alpha in crescent development and its modulation by cytokine blockade.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8959617     DOI: 10.1681/ASN.V7112271

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  22 in total

1.  Pancreatitis and duodenitis from sarcoidosis: successful therapy with mycophenolate mofetil.

Authors:  Andrew S O'Connor; Farhad Navab; Michael J Germain; Jonathan K Freeman; Jeffrey G Mulhern; Michael H O'Shea; George S Lipkowitz; Robert L Madden; Gregory L Braden
Journal:  Dig Dis Sci       Date:  2003-11       Impact factor: 3.199

2.  Macrophage apoptosis in rat crescentic glomerulonephritis.

Authors:  H Y Lan; H Mitsuhashi; Y Y Ng; D J Nikolic-Paterson; N Yang; W Mu; R C Atkins
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

3.  Anti-macrophage-derived chemokine antibody relieves murine lupus nephritis.

Authors:  Haina Liu; Cheng Diao; Chunling Wu; Liping Xia; Hongmei Duan; Fang Fang; Shuang Ding; Weiguo Xiao
Journal:  Rheumatol Int       Date:  2010-05-15       Impact factor: 2.631

4.  A new function for parietal epithelial cells: a second glomerular barrier.

Authors:  Takamoto Ohse; Alice M Chang; Jeffrey W Pippin; George Jarad; Kelly L Hudkins; Charles E Alpers; Jeffrey H Miner; Stuart J Shankland
Journal:  Am J Physiol Renal Physiol       Date:  2009-09-30

5.  Voltage-gated potassium channel Kv1.3 blocker as a potential treatment for rat anti-glomerular basement membrane glomerulonephritis.

Authors:  Toshitake Hyodo; Takashi Oda; Yuichi Kikuchi; Keishi Higashi; Taketoshi Kushiyama; Kojiro Yamamoto; Muneharu Yamada; Shigenobu Suzuki; Ryota Hokari; Manabu Kinoshita; Shuhji Seki; Hidehiko Fujinaka; Tadashi Yamamoto; Soichiro Miura; Hiroo Kumagai
Journal:  Am J Physiol Renal Physiol       Date:  2010-09-01

6.  Glomerular permselectivity factors are not responsible for the increase in fractional clearance of albumin in rat glomerulonephritis.

Authors:  K A Greive; D J Nikolic-Paterson; M A Guimarães; J Nikolovski; L M Pratt; W Mu; R C Atkins; W D Comper
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

7.  Albumin-induced apoptosis of glomerular parietal epithelial cells is modulated by extracellular signal-regulated kinase 1/2.

Authors:  Alice M Chang; Takamoto Ohse; Ron D Krofft; Jimmy S Wu; Allison A Eddy; Jeffrey W Pippin; Stuart J Shankland
Journal:  Nephrol Dial Transplant       Date:  2011-09-05       Impact factor: 5.992

8.  Expression of lymphotactin mRNA in experimental crescentic glomerulonephritis.

Authors:  Y Natori; Z L Ou; Y Yamamoto-Shuda; Y Natori
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

9.  [Fabry's disease, glomerulonephritis with crescentic and granulomatous interstitial nephritis. Case of one family].

Authors:  J Kriegsmann; M Otto; E Wandel; A Schwarting; J Faust; T Hansen; J Beck; C Whybra; M Beck
Journal:  Pathologe       Date:  2003-10       Impact factor: 1.011

Review 10.  Henoch-Schönlein purpura nephritis in children.

Authors:  Jean-Claude Davin; Rosanna Coppo
Journal:  Nat Rev Nephrol       Date:  2014-07-29       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.